Skip to main content
Coreo AG logo

Coreo AG — Investor Relations & Filings

Ticker · CORE ISIN · DE000A40KYB8 LEI · 391200FQ2JQTU4IUY679 F Real estate activities
Open in API
Filings indexed 417 across all filing types
Latest filing 2009-10-01 Regulatory Filings
Country DE Germany
Listing F CORE

About Coreo AG

https://coreo.de/en/

Coreo AG is a real estate investment company focused on the acquisition, development, and management of residential and commercial properties. The company's strategy centers on value-add opportunities, targeting properties with significant potential for appreciation. Coreo AG employs an active 'manage to core' approach to sustainably increase the value of its assets, with the goal of building and expanding an efficiently managed, high-yield real estate portfolio. Investment focus is primarily on residential properties, preferably in medium-sized centers, with individual investment volumes typically ranging from 5 to 20 million euros. The company's portfolio comprises a mix of residential, commercial, and combined-use properties.

Recent filings

Filing Released Lang Actions
Nanocoating by Nanostart holding ItN Nanovation is flying to the Mercury
Regulatory Filings Classification · 100% confidence The document is a news release dated October 1, 2009, disseminated via DGAP, announcing that Nanostart holding ItN Nanovation has been selected as a project partner by the European Space Agency (ESA) for the BepiColombo mission to Mercury to develop thermal coatings. This is a general corporate announcement regarding a significant business contract/development, not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial event like a dividend (DIV) or capital change (CAP). It fits best under the general category for miscellaneous corporate news that doesn't fit other specific financial reporting types, which aligns with the Regulatory Filings (RNS) definition, often used for press releases about business developments.
2009-10-01 English
Zwischenbericht 30.Juni 2009
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Halbjahresbericht 2009' (Half-Year Report 2009) for Nanostart AG. It contains detailed financial information, including a balance sheet, profit and loss statement, management discussion on financial performance, and a breakdown of the investment portfolio (Net Asset Value). Since it covers a period shorter than a full fiscal year (first half of 2009) and includes substantive financial data and analysis, it is classified as an Interim/Quarterly Report. H2 2009
2009-09-30 German
Fund Information / Factsheet 2009
Fund Information / Factsheet Classification · 99% confidence The document appears to be a high-level overview or promotional material about Nanostart AG, an investment company focused on nanotechnology. It discusses the company's vision, investment strategy, portfolio focus (healthcare, cleantech, energy, IT), management expertise, market potential of nanotechnology, and contact information. It reads like an introductory document designed to inform potential investors about the company's value proposition and market outlook. This content structure is highly characteristic of an Investor Presentation (IP) or a Fund Information/Factsheet (FS). Given the depth of discussion on market potential, strategy, and the inclusion of quotes and growth projections, 'Investor Presentation' (IP) is the most fitting classification over the very brief 'Fund Information/Factsheet' (FS). It is not a formal regulatory filing like 10-K, an earnings release (ER), or a management discussion (MDA) which typically accompanies financial statements.
2009-09-28 English
Nanostart subsidiary MagForce: Patient recruitment for phase II clinical trials for Nano-Cancer(R) therapy successfully completed
Legal Proceedings Report Classification · 99% confidence The document is a short corporate news release dated September 23, 2009, disseminated via DGAP. It announces a critical operational milestone: the successful completion of patient recruitment for phase II clinical trials for a cancer therapy by a subsidiary (MagForce). It discusses future plans for regulatory approval and sales, but it is not a full financial report (like 10-K or IR), an earnings release (ER), or a formal legal filing. Since it is a general corporate announcement regarding business progress that doesn't fit neatly into the other specific categories (like M&A, Dividend, Management Change), it falls best under the general Regulatory Filings/Miscellaneous category, RNS, as per the provided definitions and the 'Menu vs Meal' rule (it's an announcement, not the final report).
2009-09-23 English
Nanostart-Beteiligung ItN Nanovation AG verauert Betriebsstatte in Halberstadt
Regulatory Filings Classification · 100% confidence The document is a news release dated September 11, 2009, announcing that Nanostart's investment, ItN Nanovation AG, sold a production facility (Betriebsstätte) to CWT Clean Tec AG for 2.5 million Euros. This is a specific corporate action related to asset disposal and restructuring, which is not explicitly covered by the primary financial report codes (10-K, IR, ER). It details a significant transaction affecting the company's structure and finances. Since it is a general corporate news announcement about a transaction that is not a merger/takeover (TAR), insider dealing (DIRS), or capital change (CAP/SHA), it best fits the general regulatory announcement category, which is 'Regulatory Filings' (RNS) as a fallback for miscellaneous corporate news, or potentially 'Transaction in Own Shares' (POS) if the sale was interpreted as a divestiture of a business unit, but RNS is safer for general corporate news releases not fitting other specific transactional types. Given the nature of the announcement (sale of a business unit/asset), it is a significant corporate event announcement. Since there is no specific code for 'Asset Sale' or 'Divestiture', RNS (Regulatory Filings/Miscellaneous Announcement) is the most appropriate fallback for this type of news release.
2009-09-11 German
Umfangreiche Projektfordermittel der EU fur Nanostart-Beteiligung ItN Nanovation AG
Capital/Financing Update Classification · 99% confidence The document is a short news release dated September 11, 2009, announcing that Nanostart's holding, ItN Nanovation AG, will participate in the multinational EU-funded 'Henix' project to develop nanotechnological cooling fluids. It details the project goals, funding amount (six-figure Euro range), and quotes management. The text explicitly states it is a 'Veröffentlichung einer Corporate News, übermittelt durch die DGAP' (Publication of a Corporate News, transmitted by DGAP). This format—a brief announcement of a business development, partnership, or funding success, rather than a formal regulatory report (like 10-K, IR, or ER)—fits best under the general category for miscellaneous regulatory announcements or news releases that don't fit specific financial reporting codes. Since it is not a formal financial report, a dividend notice, or a management change, the most appropriate fallback category is Regulatory Filings (RNS), as it is a general corporate announcement disseminated via a news service (DGAP). It is too specific for RNS if a better fit existed, but none of the other codes (like CAP for financing, or LTR for legal) apply directly to a project participation announcement.
2009-09-11 German

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.